202 related articles for article (PubMed ID: 20065653)
1. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.
Montgomery DL; Wang YJ; Hrin R; Luftig M; Su B; Miller MD; Wang F; Haytko P; Huang L; Vitelli S; Condra J; Liu X; Hampton R; Carfi A; Pessi A; Bianchi E; Joyce J; Lloyd C; Geleziunas R; Bramhill D; King VM; Finnefrock AC; Strohl W; An Z
MAbs; 2009; 1(5):462-74. PubMed ID: 20065653
[TBL] [Abstract][Full Text] [Related]
2. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
Rubio AA; Filsinger Interrante MV; Bell BN; Brown CL; Bruun TUJ; LaBranche CC; Montefiori DC; Kim PS
J Virol; 2021 Jul; 95(15):e0235020. PubMed ID: 33980592
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41.
Sabin C; Corti D; Buzon V; Seaman MS; Lutje Hulsik D; Hinz A; Vanzetta F; Agatic G; Silacci C; Mainetti L; Scarlatti G; Sallusto F; Weiss R; Lanzavecchia A; Weissenhorn W
PLoS Pathog; 2010 Nov; 6(11):e1001195. PubMed ID: 21124990
[TBL] [Abstract][Full Text] [Related]
4. Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.
Gustchina E; Louis JM; Frisch C; Ylera F; Lechner A; Bewley CA; Clore GM
Virology; 2009 Oct; 393(1):112-9. PubMed ID: 19695655
[TBL] [Abstract][Full Text] [Related]
5. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41.
Gustchina E; Li M; Louis JM; Anderson DE; Lloyd J; Frisch C; Bewley CA; Gustchina A; Wlodawer A; Clore GM
PLoS Pathog; 2010 Nov; 6(11):e1001182. PubMed ID: 21085615
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.
Ofek G; Zirkle B; Yang Y; Zhu Z; McKee K; Zhang B; Chuang GY; Georgiev IS; O'Dell S; Doria-Rose N; Mascola JR; Dimitrov DS; Kwong PD
J Virol; 2014 Mar; 88(5):2426-41. PubMed ID: 24335316
[TBL] [Abstract][Full Text] [Related]
8. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
[TBL] [Abstract][Full Text] [Related]
9. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
[TBL] [Abstract][Full Text] [Related]
11. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
Wu C; Raheem IT; Nahas DD; Citron M; Kim PS; Montefiori DC; Ottinger EA; Hepler RW; Hrin R; Patel SB; Soisson SM; Joyce JG
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2317230121. PubMed ID: 38768344
[TBL] [Abstract][Full Text] [Related]
12. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
Zwick MB; Komori HK; Stanfield RL; Church S; Wang M; Parren PW; Kunert R; Katinger H; Wilson IA; Burton DR
J Virol; 2004 Mar; 78(6):3155-61. PubMed ID: 14990736
[TBL] [Abstract][Full Text] [Related]
13. Germlining of the HIV-1 broadly neutralizing antibody domain m36.
Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS
Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
[TBL] [Abstract][Full Text] [Related]
15. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
Montefiori DC; Filsinger Interrante MV; Bell BN; Rubio AA; Joyce JG; Shiver JW; LaBranche CC; Kim PS
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431684
[TBL] [Abstract][Full Text] [Related]
16. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
17. Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region.
Ofek G; McKee K; Yang Y; Yang ZY; Skinner J; Guenaga FJ; Wyatt R; Zwick MB; Nabel GJ; Mascola JR; Kwong PD
J Virol; 2010 Mar; 84(6):2955-62. PubMed ID: 20042512
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.
Conley AJ; Kessler JA; Boots LJ; Tung JS; Arnold BA; Keller PM; Shaw AR; Emini EA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3348-52. PubMed ID: 7512731
[TBL] [Abstract][Full Text] [Related]
19. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
[TBL] [Abstract][Full Text] [Related]
20. Side chain requirements for affinity and specificity in D5, an HIV-1 antibody derived from the VH1-69 germline segment.
Stewart A; Harrison JS; Regula LK; Lai JR
BMC Biochem; 2013 Apr; 14():9. PubMed ID: 23566198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
